Current NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4mg, and TA664 for liraglutide 3.0mg) does not include inflammatory conditions as indications
It is recognized for its potential to target inflammatory pathways and support immune regulation, adding an extra layer of inflammation and recovery support on top of the shared three-peptide base
Normally, treatment consists of carnitine supplementation along with the therapy of the condition that is causing the deficiency
With Compounded Tirzepatide, you embark on a path of transformation, where each step is guided by science, efficacy, and a commitment to your well-being
What you will not find is anything close to the evidence base those numbers suggest
Here are the key reasons patients choose our clinic: Our peptide-based metabolic programs are guided by experienced medical professionals within a functional medicine framework for safe and ethical care